Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Bosch

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Plos One|April 8, 2025
Correction: High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcomeChristopher Godina, Somayeh Khazaei, Mattias Belting, et al.
Cirugia Espanola|October 6, 2007
[Effect of neoadjuvant chemotherapy on the results of resection of colorectal liver metastases]Purificación Ivorra, Luis Sabater, Julio Calvete, et al.
Carcinogenesis|October 4, 2021
Prognostic impact of tumor-specific insulin-like growth factor binding protein 7 (IGFBP7) levels in breast cancer: a prospective cohort studyChristopher Godina, Somayeh Khazaei, Helga Tryggvadottir, et al.
The Biochemical Journal|January 8, 2009
Nitration of cathepsin D enhances its proteolytic activity during mammary gland remodelling after lactationRosa Zaragozá, Luis Torres, Concha García, et al.
Breast Cancer Research and Treatment|December 10, 2024
Evaluation of alternative prognostic thresholds for SP142 and 22C3 immunohistochemical PD-L1 expression in triple-negative breast cancer: results from a population-based cohortGudbjörg Sigurjonsdottir, Tommaso De Marchi, Anna Ehinger, et al.
Breast (Edinburgh, Scotland)|July 2, 2013
An evaluation of the impact of technical bias on the concordance rate between primary and recurrent tumors in breast cancerJose A Pérez-Fidalgo, Pilar Eroles, Jaime Ferrer, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|December 20, 2011
NF-ĸB as node for signal amplification during weaningLuis Torres, Eva Serna, Ana Bosch, et al.
Breast Cancer Research and Treatment|May 9, 2008
Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patientsIsabel Chirivella, Begoña Bermejo, Amelia Insa, et al.
Eclinicalmedicine|December 5, 2024
The analytical and clinical validity of AI algorithms to score TILs in TNBC: can we use different machine learning models interchangeably?Joan Martínez Vidal, Nikos Tsiknakis, Johan Staaf, et al.
Breast Cancer Research : BCR|February 11, 2021
Molecular analyses of triple-negative breast cancer in the young and elderlyMattias Aine, Ceren Boyaci, Johan Hartman, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Plos One|April 8, 2025
Correction: High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcomeChristopher Godina, Somayeh Khazaei, Mattias Belting, et al.
Cirugia Espanola|October 6, 2007
[Effect of neoadjuvant chemotherapy on the results of resection of colorectal liver metastases]Purificación Ivorra, Luis Sabater, Julio Calvete, et al.
Carcinogenesis|October 4, 2021
Prognostic impact of tumor-specific insulin-like growth factor binding protein 7 (IGFBP7) levels in breast cancer: a prospective cohort studyChristopher Godina, Somayeh Khazaei, Helga Tryggvadottir, et al.
The Biochemical Journal|January 8, 2009
Nitration of cathepsin D enhances its proteolytic activity during mammary gland remodelling after lactationRosa Zaragozá, Luis Torres, Concha García, et al.
Breast Cancer Research and Treatment|December 10, 2024
Evaluation of alternative prognostic thresholds for SP142 and 22C3 immunohistochemical PD-L1 expression in triple-negative breast cancer: results from a population-based cohortGudbjörg Sigurjonsdottir, Tommaso De Marchi, Anna Ehinger, et al.
Breast (Edinburgh, Scotland)|July 2, 2013
An evaluation of the impact of technical bias on the concordance rate between primary and recurrent tumors in breast cancerJose A Pérez-Fidalgo, Pilar Eroles, Jaime Ferrer, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|December 20, 2011
NF-ĸB as node for signal amplification during weaningLuis Torres, Eva Serna, Ana Bosch, et al.
Breast Cancer Research and Treatment|May 9, 2008
Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patientsIsabel Chirivella, Begoña Bermejo, Amelia Insa, et al.
Eclinicalmedicine|December 5, 2024
The analytical and clinical validity of AI algorithms to score TILs in TNBC: can we use different machine learning models interchangeably?Joan Martínez Vidal, Nikos Tsiknakis, Johan Staaf, et al.
Breast Cancer Research : BCR|February 11, 2021
Molecular analyses of triple-negative breast cancer in the young and elderlyMattias Aine, Ceren Boyaci, Johan Hartman, et al.
Pageof 5